Journal
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Volume 63, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jddst.2021.102471
Keywords
Domperidone; Chitosan; Ethyl cellulose; Microspheres; Nasal drug delivery; Bioavailability
Categories
Funding
- Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia [375213500]
- Central Laboratory, Jouf University, Sakaka, AlJouf, Saudi Arabia
Ask authors/readers for more resources
The study focused on developing CH-EC based microspheres for nasal delivery of DOM to improve its bioavailability. In vivo experiments showed that the optimized DOM microspheres had higher relative bioavailability compared to nasally administered DOM solution and orally administered DOM-Sol & ComTab.
The strategies to avoid the first-pass metabolism via nose to systemic pathway are been explored to improve the bioavailability of the therapeutic agents. The present study aimed to formulate and evaluate the chitosan (CH)ethylcellulose (EC) based microspheres for the systemic delivery of domperidone (DOM) via the nasal route to improve its bioavailability which is poor (18%) owing to the extensive first-pass metabolism. The microspheres were prepared by the solvent evaporation method and evaluated for certain in-vitro and in-vivo parameters. Invivo study for optimized DOM-Microsphs (F1) formulation was performed on Wistar rats for the evaluation of bioavailability and pharmacokinetic parameters after nasal administration and compared to nasally administered DOM solution (DOM-Sol), and orally administered DOM-Sol & commercially available tablet formulation (ComTab). In-vitro results of optimized formulation (F1) demonstrated that the microspheres were spherical with 21.12 +/- 0.51 mu m particle size, 84.79 +/- 1.39% entrapment efficiency, 50.68 +/- 0.96% drug loading, 81.2 +/- 6.75% drug release in 8 h. DOM loaded microspheres demonstrated 2 fold ex-vivo permeation than that Com-Tab. X-ray diffraction and differential scanning calorimetry spectra do not display the characteristic peak of DOM, thus recommending the encapsulation of the drug in the polymeric core. The relative bioavailability of optimized formulation administered nasally in comparison to DOM-Sol administered orally, DOM Com-Tab administered orally, and DOM-Sol administered nasally was found to be 3.75, 2.61, and 1.77 folds respectively indicating the superiority of developed formulation. The developed microspheres were found to be promising for the bioavailability enhancement of DOM through the nasal route by avoiding its first-pass metabolism. Therefore, the development of microspheres for nasal to systemic route might better choice and a finer option for DOM bioavailability enhancement as well as for avoiding the problem associated with the drug due to irregular drug concentration in the blood with oral administration of the conventional formulation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available